Friday, November 08, 2019 5:36:16 AM
In terms of SIPC - very high risk investment. As is every OTC issue. But SIPC files regularly and they have a verifiable product selling in stores today. And while the footprint is small, it is expanding.
As for common shares, SIPC does not dilute on top of a great share structure. The debt in terms of potential dilution is exceptionally minor, owed largely to the owners of the company who provide funding vehicles in order to keep the operation running.
This is a small business right now. Outstanding shares are less than 350mm and the market cap as of this writing is less than $2.5mm.
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM